- It’s a grand plan to depopulate Africa – Scientists.
- It is made with public health in mind; side effects are reversible – Pfizer
At a Media Parley in Lagos recently, concerned researchers under the aegis of Foundation of African Cultural Heritage (FACH) presented facts and figures of a ‘Grand Plan’ by the Western World to depopulate Africa and destroy family values among others with Nigeria as their prime target. GBUBEMI GOD’S COVENANT SNR was there.
The process of the alleged world conspiracy against African families to deplete population and dismount family structures and values is through a cheap contraceptive supposed to help poor women control their birth rate.
Their network includes Family Planning organisations like PPFN, USAID, UKaid, UNFPA, IPAS, Marie Stopes etc. The project is funded by Bill and Melinda Gates foundation and other international donors.
Though the project has been ongoing for many years before now, a wider international campaign started in November 2014 when one of the world’s richest men in the world and his wife, Bill and Melinda Gates, through their Foundation, announced that they have joined the Children’s Investment Fund Foundation (CIFF) and Pfizer Incorporated, to ‘help’ 120 million women in the world’s 69 poorest countries with access to voluntary family planning by 2020 at $1 dollar per dose.
While the BBC and other Western Medias of note celebrated and encouraged the move, concerned medical experts across the globe raised alarm over the deadliness and long term consequences of using the self injectable contraceptive.
35 years old Ujunwa Ekeocha, a biomedical scientist practicing in Canterbury, England and Doctor Nkechi Osogwa, both Nigerian citizens led a group of researchers in a Media Discourse with journalists in Lagos recently to expose how Western World is destroying Africa by making us believe that we are over populated.
Among the speakers was Brian Clowes from Human Life International who talked about a top secret document titled “National Security Study Memorandum 200 (MSSM-200) also known as The Kissinger Report which has been classified by the White House in 1989. The document was subtitled ‘Implications of Worldwide Population Growth for U.S. Security and Overseas Interests.’
Debilitating harm of Depo Provera and Sayana Press
Analysis by experts state that the pharmaceutical Depo Provera belong to a category of dangerous progesterone contraceptives, e.g. Norplant, which are restricted by the FDA in the United States with “Black Box Warnings”, and branded the “DDT of contraceptives” by human rights advocates, because they are highly toxic and have debilitating and lethal side-effects; also, both have been banned or restricted in Europe, India, Israel and the Middle East.
A former brand in the range, Norplant, was pulled from U.S. markets in 2002 after multimillion dollar settlements by Pfizer. However, Pfizer now avoids U.S. lawsuits by licensing Norplant to European corporation Bayer, and sells Norplant and DMPA to Africans and developing countries through institutional intermediaries such as the Population Council and United States Agency for International Development (USAID). According to the Wall Street Journal, Pfizer through a partnership with Bill and Melinda Gates will earn approximately 36 billion dollars in new Depo Provera sales annually.
In a swift reaction to the Bill and Melinda Gates announcement on the contraceptives, biomedical scientist wrote to Melinda Gates to question her rationale behind targeting of her project to African women and children.
Part of her letter reads:
“$4.6 billion dollars can indeed be your legacy to Africa and other poor parts of the world. But let it be a legacy that leads to life, love and laughter into the world in need.
“I see this $4.6 billion buying us misery. I see it buying us unfaithful husbands. I see it buying us streets devoid of the innocent chatter of children. I see it buying us disease and untimely death. I see it buying us a retirement without the tender loving care of our children. Please Melinda, listen to the heart-felt cry of an African woman and mercifully channel your funds to pay for what we REALLY need.
“Rather than fill our defenseless under-aged brides with Depo-Provera — which is more like a general anaesthesia that will numb them to the brutality of their reality — we can better empower them by giving them an education, which becomes the lifeline by which they can climb out of poverty one girl at a time. Surely education is more expensive than the artificial contraceptive, but it can change the fate and face of Africa as far as poverty is concerned.”
To the African woman, the target of this Western Project, Uju sends this plea: “Of all the ‘help’ Western ‘sympathisers’ decided to offer to poor women, if it does not address important basic needs like poverty, housing, education, employment and quality healthcare, consider any other alternative help a Greek gift; that is, a gift which your enemy will pass through to destroy you in a way you cannot suspect, and by the time you realise it, it would be too late.”
The offer of contraceptives to African women, the group points out, is to depopulate Nigeria by exposing the women to double risk of breast cancer, prolonged bleeding, delayed return of fertility and severe cases of osteoporosis. All that is grammar: the goal is to make the Nigerian woman sterile, she emphasised.
Daily Times reproduce here an article written by one Lisa Correnti and published in the New York Times of November 14, 2014. The article chronicled international outcry and condemnation of Depo Provera and Sayana Press and reads in part:
New York Times Whitewashes Dangerous Contraceptive for Poor Women
By Lisa Correnti | November 14, 2014
Big pharma, a rich philanthropist, government aid and a children’s non-profit announced yesterday (November 13th) that they would make a controversial injectable contraceptive more widely available to poor women in developing countries.
The New York Times trumpeted the announcement that Pfizer Inc., the Bill & Melinda Gates Foundation, and the Children’s Investment Fund Foundation (CIFF) will provide financing to assure the new self-inject version of Depo Provera – called Sayana Press would reach millions of women in rural areas.
Sayana Press like its predecessor Depo Provera, is a dangerous progesterone contraceptive. Some 11 scientific studies revealed an increased risk of contracting and transmitting HIV/AIDS among women using Depo Provera. Women using these progesterone contraceptives double the risk of breast cancer, have prolonged bleeding, delayed return of fertility, and are at greater risk to develop severe cases of osteoporosis. For this reason the FDA issued a black-box warning that it shouldn’t be used beyond 2 years.
Yet, in sub-Sahara Africa women have been using Depo Provera for years and know nothing of the long term consequences.
PATH developed the self-inject delivery system through funding by USAID and others. Reproductive health expert Kwame Fosu says the new delivery system will circumvent mandatory informed consent required by the FDA for drugs with black box warnings.
Fosu has been sounding the alarm on the serious side effects to US lawmakers in Washington and to African delegates at the United Nations.
Depo Provera stakeholders — the Gates Foundation, USAID, and reproductive rights groups that claim to have a woman’s best interest, remain quiet on the side effects. And now, a major media outlet.
The NY Times article has no mention of the controversy around progesterone contraceptives. What is reproductive choice or voluntary family planning without informed consent?
The $14 billion for “population assistance” directed to intermediaries like UNFPA, IPPF, Marie Stopes, FHI360, and PATH have a secure funding stream implementing family planning programs that prioritize long-acting contraceptives like injectables and implants. Some $8 billion is targeted to sub-Sahara Africa.
Partners on this new effort to distribute Sayana Press to women and girls of reproductive age include the U.S. Agency for International Development (USAID), the UK Department for International Development (DFID), the United Nations Population Fund (UNFPA), and PATH
“In the place of our real needs they offer us a product that we have neither wanted nor demanded,” said Obianuju Ekeocha, founder of Culture of Life Africa. “It is heart-breaking to see how these wealthy proponents of contraception have chosen to unleash their extensive projects on Africa with programs overlooking the real needs of African women, which include access to good education, good healthcare, food and water,” continued Ekeocha.
Depo Provera and the progesterone implant Jadelle (Norplant 2) are targeted to poor women only. Women in Europe and the US do not use it. Norplant 1 was withdrawn from the US market after thousands of lawsuits filed by women harmed by the side effects. It since has been licensed to be manufactured off-shore.
These aggressive programs will be successful in lowering fertility in these regions but will do nothing to provide economic gain and lift women from poverty. With harmful pharmaceuticals like these, poor women will have less children – but they will remain poor, and now, will have health issues that won’t be addressed by sub-standard healthcare systems.”
In response to Daily Times email to Pfizer Pharmaceuticals Incorporated on the international outcry over its controversial contraceptives, details of a press conference held recently were made available to our correspondent.
Denying far reaching allegations against their products, Mr. John Young, President, Pfizer Global Established Pharma Business who is also in charge of Pfizer’s array of generic medicines, said:
“Novel Agreement Expands Access to Pfizer’s Contraceptive, Sayana® Press, for Women Most in Need in the World’s Poorest Countries. Collaboration will help advance progress and support global efforts to increase access to voluntary family planning information, services and contraceptives by 2020. It’s a simple way to increase access to women who want contraception, in a setting where there may be limited healthcare systems.”
On the side effects, Young explained:
“Sayana® Press combines a long-acting, reversible, contraceptive with an all-in-one prefilled, single-use, non-reusable Uniject™ injection system. It is indicated for the prevention of pregnancy. Each subcutaneous injection prevents ovulation and provides contraception for at least 13 weeks (+/- one week). Sayana® Press professional and patient information, including the risk of bone mineral density loss and other warnings and precautions are clearly stated.
Dr. Ariel Pablos-Mendez, Assistant Administrator for Global Health, USAID said at the conference that USAID has invested in Sayana® Press for many years, “and we are thrilled that these efforts have finally come to fruition. This public-private collaboration will now help more women access injectable contraceptives. Expanding contraceptive choice is crucial to helping women plan and space their pregnancies, which we believe contributes to the health and economic wellbeing of families and communities across the globe.”
Healthcare giver and social worker formerly attached to SOS Children’s Village, Ms Yomi Adeosun who was at a Press Parley with an international agency, the Foundation of African Cultural Heritage (FACH). She said of Sayana Press:
“I am a Family Planning Provider; I studied and did family planning as a course. It was a good thing I attended that programme because I didn’t know that Depo Provera was already causing trouble. Two weeks before that programme, I had a client who said she was through with childbearing, and her husband has said he will no longer use condom.
“I don’t recommend it for people who still want to have children. I met that woman after that conference with FACH and I had to tell her ‘Please, Mama Bose, don’t use that Depo again’, and I had to tell her that there are some things I heard about it last week.’
Yomi worried that among health professionals, the dangerous side effects of Depo Provera were not known before and even now, because specific warnings did not accompany the packs.
“Back in the 1980s, while I was in active practice, a young unmarried doctor in our group took just one Depo Provera and her menses seized for more than one year. We worked together in some hospitals in Lagos and all the time her menses did not return, and we were all troubled; even as health providers with special bias for family planning, we didn’t know about the side effects of Depo Provera, so how can rural women, even urban women suspect or know anything like that? It is upsetting and worrisome.”
A woman’s advocate and CEO of Kemskis Well Woman Health Center, Kemi Ogunyemi, MSN, MHA, OCN in her reaction to Daily Times vide email wrote:
Depo Provera was approved by the FDA in 1990 in response to concerns about the population explosion in the 3rd world. However, countries like India, Canada, Zimbabwe and India have had to either ban the drug or have had lawsuits filed against them because of the adverse side effects like Osteoporosis and Cervical cancer.
Now we have Sayana Press, which is basically the same as Depo Provera, except in a new outer wrap. It is in the trial phase in Sub Sahara Africa and not in the US or UK. Why? Why target African women who are vulnerable to drugs like this from developed countries? Should the African woman be the lab rat for a drug that may have side effects that could be fatal in the long run?
African women are not going to ask questions about possible side effects especially when the drug is being given free.
Women are easy targets for exploitation and need to be protected by their governments and those in charge of the health and well-being.
US lawmakers, the likes of Bill and Melinda Gates Foundation, USAID etc have been quiet about the side effects concerns. Why?
In Africa, we already have health issues like increase in Cervical and breast cancer, heart attacks, increase in maternal and child mortality etc. The last think we need is an increase in long-term illnesses and diseases in the quest to prevent pregnancy for free.
Officials of the Planned Parenthood Federation of Nigeria (PPFN) at Palmgrove, Ikorodu Road, Lagos declined to comment on Sayana Press and referred all inquiries to the ministry of health.
A top official at the office of the reappointed Federal Minister of Health who craved anonymity, told our correspondent in a telephone chat that the Honourable Minister, Professor Onyebuchi Chukwu is busy with preparations for the May 29th programme.
Similarly, visits made to office of the Lagos State Ministry of Health, Alausa was unsuccessful as the office is virtually empty of senior officers. An insider hinted that no business would be attended to until the incoming government comes in come May 29th.
Bill & Melinda Gates Foundation
When Daily Times contacted Bill & Melinda Foundation through their internet link, the following statement was posted on their website:
“Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty.
“In the United States, it seeks to ensure that all people -especially those with the fewest resources – have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Sue Desmond-Hellmann and Co-Chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.
For further information, please contact email@example.com.